In the Canadian biotechnology sector, R&D intensity is projected to rise steadily from 2024 to 2028. The percentage of value added is set to increase from 0.85% in 2024 to 1.1% by 2027, maintaining that level in 2028. This indicates a strong upward trend, with an average annual growth rate calculated over five years. The recent two-year period suggests increasing year-on-year growth rates, underscoring the sector's expanding focus on innovation.
Future trend considerations include:
- Continued investment in research to drive competitiveness and innovation.
- Potential policy changes affecting R&D incentives or funding.
- Technological advancements potentially influencing intensity measures.
